Clinical Study
Influence of APOE Genotype on Alzheimer’s Disease CSF Biomarkers in a Spanish Population
Table 3
Influence of age on CSF AD variables.
| CSF variables | Age | Number of patients | Mean ± SD | Significance level | Adjusted significance level |
| Aβ protein (pg/mL) | ≥75 <75 | 16 40 | 858.63 ± 457.41 1146.1 ± 444.34 | 0.03 | 0.06 |
| T-tau protein (pg/mL) | ≥75 <75 | 16 40 | 381.75 ± 172.46 283.18 ± 218.34 | 0.11 | 0.38 |
| | | | Median (25–75) | | |
| p-tau protein (pg/mL) | ≥75 <75 | 16 40 | 59 (52.0–88.68) 40 (42.1–60.15) | 0.01 | 0.21 |
| Ratio T-tau/Aβ | ≥75 <75 | 16 40 | 0.42 (0.35–0.74) 0.16 (0.21–0.45) | 0.007 | 0.26 |
| Ratio p-tau/Aβ | ≥75 <75 | 16 40 | 0.07 (0.05–0.15) 0.03 (0.04–0.07) | 0.004 | 0.09 |
|
|
Student’s -test. Mann-Whitney test.
|